Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States

Journal of Heart and Lung Transplantation

Volumn 31, Issue 12, 2012, Pages 1241-1252

  Acker, Michael A ^a   Pagani, Francis D ^b   Stough, Wendy Gattis ^c   Mann, Douglas L ^d   Jessup, Mariell ^a   Kormos, Robert ^e   Slaughter, Mark S ^f   Baldwin, Timothy ^g   Stevenson, Lynne ^h   Aaronson, Keith D ⁱ   Miller, Leslie ^j   Naftel, David ^k   Yancy, Clyde ^l   Rogers, Joseph ^m   Teuteberg, Jeffrey ⁿ   Starling, Randall C ^o   Griffith, Bartley ^p   Boyce, Steven ^q   Westaby, Stephen ^r   Blume, Elizabeth ^s   Wearden, Peter ^t   Higgins, Robert ^u   MacK, Michael ^v   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c CAMPBELL UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f University of Louisville School of Medicine   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k Kentucky   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^o LERNER RESEARCH INSTITUTE   (United States)

^p UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^q WASHINGTON HOSPITAL CENTER   (United States)

^r JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^s BOSTON CHILDREN S HOSPITAL   (United States)

^t CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^u OHIO STATE UNIVERSITY   (United States)

^v MEDICAL CITY DALLAS HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DEVICE SAFETY; DEVICE THERAPY; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HUMAN; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; RISK BENEFIT ANALYSIS; SURVIVAL; TECHNOLOGY; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR ASSIST DEVICE;

CHILD; CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; EUROPE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; JAPAN; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES; UNITED STATES;

EID: 84870505477     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.10.012     Document Type: Article

References (37)

1. D.R. Challoner, and W.W. Vodra Medical devices and health - creating a new regulatory framework for moderate-risk devices N Engl J Med 365 2011 977 979
2. G.D. Curfman, and R.F. Redberg Medical devices - balancing regulation and innovation N Engl J Med 365 2011 975 977
3. R.G. Hauser Here we go again - failure of postmarketing device surveillance N Engl J Med 366 2012 873 875
4. D.B. Kramer, S. Xu, and A.S. Kesselheim Regulation of medical devices in the United States and European Union N Engl J Med 366 2012 848 855
5. F.S. Resnic, and S.L. Normand Postmarketing surveillance of medical devices - filling in the gaps N Engl J Med 366 2012 875 877
6. Hearing: regulatory reform series #5. FDA medical device regulation: impact on American patients, innovation and jobs. Available at: http://www.fda.gov/newsevents/testimony/ucm263491.htm. Accessed October 15, 2011.
7. Institute of Medicine Medical devices and the public's health: the FDA 510(k) clearance process at 35 years 2011 National Academies Press Washington, DC
8. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Third INTERMACS annual report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
9. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
10. E.A. Rose, A.C. Gelijns, and A.J. Moskowitz Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
11. M.K. Parides, A.J. Moskowitz, D.D. Ascheim, E.A. Rose, and A.C. Gelijns Progress versus precision: challenges in clinical trial design for left ventricular assist devices Ann Thorac Surg 82 2006 1140 1146
12. E. Chen, W. Sapirstein, C. Ahn, J. Swain, and B.F.D.A. Zuckerman perspective on clinical trial design for cardiovascular devices Ann Thorac Surg 82 2006 773 775
13. L.W. Miller, F.D. Pagani, and S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
14. K.D. Aaronson, H. Patel, and F.D. Pagani Patient selection for left ventricular assist device therapy Ann Thorac Surg 75 Suppl 2003 29 35
15. A.J. Boyle, D.D. Ascheim, and M.J. Russo Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
16. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
17. L.W. Stevenson, F.D. Pagani, and J.B. Young INTERMACS profiles of advanced heart failure: the current picture J Heart Lung Transplant 28 2009 535 541
18. K.D. Aaronson, M.S. Slaughter, and L.W. Miller for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
19. J.K. Kirklin, D.C. Naftel, and R.L. Kormos The frourth INTERMACS annual report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
20. D.J. Whellan, A. Nigam, and M. Arnold Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology: findings from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training study Am Heart J 162 2011 1003 1010
21. J.G. Rogers, K.D. Aaronson, and A.J. Boyle Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
22. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
23. J.A. Jarcho Resynchronizing ventricular contraction in heart failure N Engl J Med 352 2005 1594 1597
24. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
25. J.K. Kirklin, and M.R. Mehra The dawn of the ISHLT Mechanical Assisted Circulatory Support (IMACS) registry: fulfilling our mission J Heart Lung Transplant 31 2012 115 116
26. G.M. Felker, and J.G. Rogers Same bridge, new destinations re-thinking paradigms for mechanical cardiac support in heart failure J Am Coll Cardiol 47 2006 930 932
27. S.W. Glickman, J.G. McHutchison, and E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
28. S.S. Dhruva, L.A. Bero, and R.F. Redberg Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices JAMA 302 2009 2679 2685
29. A.G. Fraser, J.C. Daubert, and F. Van de Werf Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology Eur Heart J 32 2011 1673 1686
30. E. Cingolani, S. Stevens, M. Shehata, G.A. Diamond, and S. Kaul Medical device regulatory reform: insights from the Watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation Arch Intern Med 171 2011 1670 1672
31. W. Sapirstein, E. Chen, J. Swain, and B.U.S. Zuckerman FDA perspective on regulatory issues affecting circulatory assist devices Expert Rev Med Devices 3 2006 749 753
32. Food and Drug Administration Center for Devices and Radiological Health. CDRH 2011. Draft guidance for industry and food and drug administration staff: investigational device exemptions (IDE) for early feasibility medical device clinical studies, including certain first in human (FIH) studies. Available at: http://www.fda.gov/medicaldevices/deviceregulationandguidance/guidancedocuments/ ucm277670.htm 2012. Accessed August 9, 2012.
33. Food and Drug Administration Center for Devices and Radiological Health. CDRH 2012. Strategic priorities. Available at: http://www.fda.gov/downloads/ aboutfda/centersoffices/officeofmedicalproductsandtobacco/cdrh/ cdrhvisionandmission/ucm288736pdf. Accessed August 9, 2012.
34. Food and Drug Administration Center for Devices and Radiological Health. CDRH 2010. Japan-U.S. Harmonization By Doing HBD pilot program initiative, May 2010. Available at: http://www.fda.gov/medicaldevices/ deviceregulationandguidance/internationalinformation/ucm053067.html. Accessed August 9, 2012.
35. T. Yamane, S. Kyo, and H. Matsuda Japanese guidance for ventricular assist devices/total artificial hearts Artif Organs 34 2010 699 702
36. J. Lee Long-term mechanical circulatory support system reliability. Recommendation by the National Clinical Trial Initiative Subcommittee ASAIO J 55 2009 534 558
37. J.T. Baldwin, H.S. Borovetz, B.W. Duncan, M.J. Gartner, R.K. Jarvik, and W.J. Weiss The National Heart, Lung, and Blood Institute pediatric circulatory support program: a summary of the 5-year experience Circulation 123 2011 1233 1240